from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3656c/-

LFCtreatmentdescriptionclass of inhibitor

1.017

Amikacinug/mL Amikacintranslation

0.331

Cap5-10ug/mL Capreomycintranslation

0.298

Rox10-50 ug/mL Roxithromycintranslation

0.315

SM2-5 ug/mL Streptomycintranslation

-0.488

Tet5-10 ug/mL Tetracyclinetranslation

-0.967

Rif0.2-5ug/mL Rifampicintranscription

-0.187

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.280

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.456

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.199

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.397

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.323

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.365

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.360

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.114

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.621

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.817

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.194

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.773

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.561

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.470

KCN5-20 ug/mL Potassium cyaniderespiration

-0.210

NaN30.2-2 mM Sodium aziderespiration

0.008

Nigericin50 uM Nigericinrespiration

0.316

TRC10-150 ug/mL Triclosanrespiration

-0.743

TRZ10-25 ug/mL Thioridazinerespiration

1.279

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.561

menadione6-10 ug/mL Menadionerespiration

0.724

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.526

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.532

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.800

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.641

NRP_1Non-replicating persistence stage 1dosRassociated

-0.272

Amp0.2mg/mL AmpicillincellWall

0.438

Cephalexin20-100 ug/mL CephalexincellWall

-0.189

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.489

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.977

EMB10-20 ug/mL EthambutolcellWall

0.397

Eta12-40 ug/mL EthionamidecellWall

0.421

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.331

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.026

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.551

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.269

BZA0.12 mg/mL BenzamidearomaticAmides

0.018

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.476

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.306

H2O24 mM hydrogen peroxideDNAdamaging

0.265

Levo10 ug/mL LevofloxacinDNAdamaging

-0.196

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.650

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.225

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.178

UVUV-irradiationDNAdamaging

1.905

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.353

Antimycin12.5-50 ug/mL Antimycin A?

-1.167

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.019

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.348

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.340

PA8240.2-2 ug/mL PA-824?

0.228

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.332

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.413

Verapamil50 uM Verapamil?

-0.303

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.330

methoxatin10-20 ug/mL Methoxatin?